Pyridam Farma Tbk PT
IDX:PYFA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Grenke AG
XETRA:GLJ
|
DE |
|
Crossfirst Bankshares Inc
NASDAQ:CFB
|
US |
|
Altisource Portfolio Solutions SA
NASDAQ:ASPS
|
LU |
|
Sinofortune Financial Holdings Ltd
HKEX:8123
|
HK |
|
Brooks Laboratories Ltd
NSE:BROOKS
|
IN |
|
Eagle Pharmaceuticals Inc
NASDAQ:EGRX
|
US |
|
Future World Holdings Ltd
HKEX:572
|
HK |
Pyridam Farma Tbk PT
Total Receivables
Pyridam Farma Tbk PT
Total Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Pyridam Farma Tbk PT
IDX:PYFA
|
Total Receivables
Rp854.3B
|
CAGR 3-Years
69%
|
CAGR 5-Years
74%
|
CAGR 10-Years
38%
|
|
|
T
|
Tempo Scan Pacific Tbk PT
IDX:TSPC
|
Total Receivables
Rp1.7T
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
6%
|
|
|
Kalbe Farma Tbk PT
IDX:KLBF
|
Total Receivables
Rp5.9T
|
CAGR 3-Years
7%
|
CAGR 5-Years
10%
|
CAGR 10-Years
9%
|
|
|
Darya-Varia Laboratoria Tbk PT
IDX:DVLA
|
Total Receivables
Rp779.1B
|
CAGR 3-Years
7%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
|
Soho Global Health Tbk PT
IDX:SOHO
|
Total Receivables
Rp2.1T
|
CAGR 3-Years
25%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
|
Kimia Farma Tbk PT
IDX:KAEF
|
Total Receivables
Rp1.2T
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
8%
|
|
Pyridam Farma Tbk PT
Glance View
PT Pyridam Farma Tbk engages in the production and development of pharmaceutical medicines, and trading of medical supplies. The company is headquartered in Jakarta, Dki Jakarta and currently employs 1,539 full-time employees. The company went IPO on 2001-10-16. The firm operates through two segments: Pharmaceutical Products and Toll Manufacturing Services, and Medical Device Products. Its business consists of production and/or distribution of modern and traditional medicines and distribution of medical devices, such as laboratory equipment and PCR test kits. The company offers products across consumer health, prescription, pyfaesthetic and biomedilab categories. The company produces various kinds of pharmaceuticals products ranging from antibiotics, vitamins and health supplements. The firm offers its products in the form of effervescent tablets, capsules, caplets, syrups and creams. Its prescription production has several properties, such as anti-infection, anti-inflammatory, anti-parkinsonian, anti-epileptic, and other indications. The company provides toll manufacturing services to produce products owned by the Company’s partner companies in accordance with predetermined specifications.
See Also
What is Pyridam Farma Tbk PT's Total Receivables?
Total Receivables
854.3B
IDR
Based on the financial report for Sep 30, 2025, Pyridam Farma Tbk PT's Total Receivables amounts to 854.3B IDR.
What is Pyridam Farma Tbk PT's Total Receivables growth rate?
Total Receivables CAGR 10Y
38%
Over the last year, the Total Receivables growth was 38%. The average annual Total Receivables growth rates for Pyridam Farma Tbk PT have been 69% over the past three years , 74% over the past five years , and 38% over the past ten years .
